ValiRx plc (AIM:VAL)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.1500
+0.0050 (3.45%)
Nov 6, 2026, 4:27 PM GMT
ValiRx Market Cap
ValiRx has a market cap or net worth of 1.98 million as of November 6, 2026. It is the 47,105th most valuable company in the world and the 1,066th biggest in the United Kingdom. Its market cap has increased by 125.12% in one year.
Market Cap
1.98M
Enterprise Value
524.01K
Revenue
32.67K
Global Rank
Country Rank
#1,066 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 3, 2006, ValiRx's market cap has decreased from 12.83M to 1.98M, a decrease of -84.57%. That is a compound annual growth rate of -8.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.85M | -25.71% |
| Dec 31, 2025 | 2.49M | -14.24% |
| Dec 31, 2024 | 2.90M | -51.94% |
| Dec 29, 2023 | 6.04M | -33.71% |
| Dec 30, 2022 | 9.11M | -61.38% |
| Dec 31, 2021 | 23.58M | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 9.10M |
| Fusion Antibodies | 7.51M |
| CRISM Therapeutics | 7.06M |
| Solvonis Therapeutics | 6.33M |
| OptiBiotix Health | 5.69M |
| Cizzle Biotechnology Holdings | 4.76M |
| Theracryf | 4.43M |
| Futura Medical | 2.37M |